Drug Index

Elosulfase Alfa

Mechanism :

Elosulfase alfa is a recombinant form of N-acetylgalactosamine-6-sulfatase, produced in Chinese hamster cells.

Indication :

  • Mucopolysaccharidosis type IVA (Morquio A syndrome)

Contraindications :

No contraindications.

Dosing :

≥9 months:
IV 2 mg/kg once weekly.

Adverse Effect :

Headache, vomiting, nausea, abdominal pain, hypersensitivity reaction, fever, chills, fatigue, anaphylaxis.

Interaction :

No known significant interactions.

Hepatic Dose :

Specific guidelines for dosage adjustments in hepatic impairment are not available.
01/28/2024 16:10:57 Elosulfase Alfa
Disclaimer: The information given by www.pediatriconcall.com is provided by medical and paramedical & Health providers voluntarily for display & is meant only for informational purpose. The site does not guarantee the accuracy or authenticity of the information. Use of any information is solely at the user's own risk. The appearance of advertisement or product information in the various section in the website does not constitute an endorsement or approval by Pediatric Oncall of the quality or value of the said product or of claims made by its manufacturer.
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0